These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 9310280

  • 1. Effects of almokalant, a class III antiarrhythmic agent, on supraventricular, reentrant tachycardias. Almokalant Paroxysmal Supraventricular Tachycardia Study Group.
    Darpö B, Edvardsson N.
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):499-508. PubMed ID: 9310280
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Terminating supraventricular tachycardia with adenosine--comparing the effectiveness of 12 mg and 18 mg].
    Weismüller P, Kattenbeck K, Heinroth KM, Ranke C, Trappe HJ.
    Dtsch Med Wochenschr; 2000 Aug 18; 125(33):961-9. PubMed ID: 10994404
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Atypical forms of supraventricular tachycardia due to atrioventricular node reentry in children after radiofrequency modification of slow pathway conduction.
    Silka MJ, Kron J, Park JK, Halperin BD, McAnulty JH.
    J Am Coll Cardiol; 1994 May 18; 23(6):1363-9. PubMed ID: 8176094
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 9. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine.
    Chang KC, Lin YC, Chen JY, Chou HT, Hung JS.
    Cardiology; 2002 Mar 01; 97(3):138-46. PubMed ID: 12077566
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
    Lévy S, Ricard P.
    Eur Heart J; 1997 May 01; 18 Suppl C():C27-32. PubMed ID: 9152672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 17. The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
    Chiale PA, Baranchuk A, González MD, Sánchez RA, Garro HA, Fernández PA, Avalos CQ, Enriquez A, Elizari MV.
    Int J Cardiol; 2015 Jul 15; 191():151-8. PubMed ID: 25965623
    [Abstract] [Full Text] [Related]

  • 18. [Efficacy of adenosine triphosphate in terminating supraventricular tachycardia].
    Schläpfer J, Fromer M, Kappenberger L.
    Schweiz Med Wochenschr; 1993 May 08; 123(18):941-4. PubMed ID: 8497781
    [Abstract] [Full Text] [Related]

  • 19. Use of intracardiac recordings to determine the site of drug action in paroxysmal supraventricular tachycardia.
    Jackman WM, Friday KJ, Fitzgerald DM, Yeung-Lai-Wah JA, Lazzara R.
    Am J Cardiol; 1988 Dec 20; 62(19):8L-19L. PubMed ID: 3059792
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.